Silexion Therapeutics Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Silexion Therapeutics Corporation
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
/ 
Frequently asked questions
To buy Silexion Therapeutics Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Silexion Therapeutics Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Silexion Therapeutics Corporation is SLXN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Silexion Therapeutics Corporation has its primary listing on NASDAQ. You can trade Silexion Therapeutics Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Silexion Therapeutics Corporation is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Silexion Therapeutics Corporation as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Silexion Therapeutics Corporation.